Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Sophiris begins dosing in PLUS-1 phase III trial of PRX-302

Oct. 30, 2013

Enrollment complete in phase III trial of ZS-9 for treatment of hyperkalemia

Oct. 24, 2013

Evotec and AstraZeneca collaborate on treatments for chronic kidney disease

Oct. 22, 2013

Relypsa reports topline data from phase IIb trial of patiromer

Oct. 18, 2013

Phase I trial of KEA-0447/KRP-EPA605 for treatment of overactive bladder begins

Oct. 18, 2013

Relypsa announces topline data from second part of patiromer phase III trial

Oct. 11, 2013

FDA accepts filing of Zerenex NDA

Oct. 9, 2013

TRK-390 as a novel and highly selective phosphate binder

Oct. 8, 2013

AM-Pharma begins phase I trial with new recombinant AP product

Sep. 26, 2013

CHMP issues positive opinion for PSD-502 in premature ejaculation

Sep. 25, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...